Related Experiment Video
Updated: Jul 13, 2025
12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.1K
A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures
Richard J Kuhn1,2, Alan D T Barrett3,4, Aravinda M Desilva5
1Department of Biological Sciences, Purdue University, West Lafayette, Indiana, USA.
The Journal of Infectious Diseases
|October 18, 2023
Summary
Flaviviruses cause millions of infections globally, ranging from mild illness to death. Developing new vaccines is crucial due to their pandemic potential and challenges in current vaccine development.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Flaviviruses are RNA viruses transmitted by mosquitoes and ticks, causing significant global health burdens.
- Infections range from febrile illnesses to severe neurotropic and viscerotropic diseases, with notable examples including dengue and Zika viruses.
- Existing vaccines are effective for some flaviviruses, like yellow fever virus, but challenges remain for others.
Approach:
- This review synthesizes current knowledge on flavivirus infections and vaccine development.
- It identifies critical knowledge gaps hindering the creation of new vaccines.
- The focus is on understanding factors necessary for rapid vaccine development against emerging threats.
Key Points:
- Flaviviruses pose a substantial pandemic threat due to their widespread transmission and potential for severe disease.
- Vaccine development for many medically important flaviviruses remains challenging.
- Addressing knowledge gaps is essential for future flavivirus vaccine innovation.
Conclusions:
- The emergence and spread of flaviviruses underscore the urgent need for effective vaccines.
- Further research is required to overcome current limitations in flavivirus vaccine development.
- Identifying and filling knowledge gaps will accelerate the creation of vaccines against emerging flavivirus threats.
